Skip to content
10-Q

Quarterly Report

AMERICAN GENE ENGINEER CORP

0001214659-17-005675

← back to feed
Filed
Sep 19, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Sep 19, 2017 100M sh
Operating Cash Flow Q3 2017 · Jul 31, 2017 −$324.41K
Operating Cash Flow Q3 2017 · Jul 31, 2016 −$48.42K
Cash And Equivalents Q3 2017 · Jul 31, 2017 $893
Cash And Equivalents Q3 2017 · Oct 31, 2016 $308.54K
Cash And Equivalents Q3 2017 · Jul 31, 2016 $10.16K
Cash And Equivalents Q3 2017 · Oct 31, 2015 $9.55K
Stockholders Equity Q3 2017 · Jul 31, 2017 −$424.12K
Stockholders Equity Q3 2017 · Oct 31, 2016 −$182.13K
Total Liabilities Q3 2017 · Jul 31, 2017 $587.34K
Total Liabilities Q3 2017 · Oct 31, 2016 $586.82K
Current Assets Q3 2017 · Jul 31, 2017 $159.42K
Current Assets Q3 2017 · Oct 31, 2016 $400.9K
Total Assets Q3 2017 · Jul 31, 2017 $163.22K
Total Assets Q3 2017 · Oct 31, 2016 $404.7K
Sga Expense Q3 2017 · Jul 31, 2017 $80.75K
Sga Expense Q3 2017 · Jul 31, 2017 $258.75K
Sga Expense Q3 2017 · Jul 31, 2016 $23.96K
Sga Expense Q3 2017 · Jul 31, 2016 $72.46K
Net Income Q3 2017 · Jul 31, 2017 −$80.75K
Net Income Q3 2017 · Jul 31, 2017 −$258.75K
Net Income Q3 2017 · Jul 31, 2016 −$23.96K
Net Income Q3 2017 · Jul 31, 2016 −$72.46K